Literature DB >> 22402017

Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese.

Aritoshi Iida1, Naoya Hosono, Motoki Sano, Tetsumasa Kamei, Shuichi Oshima, Torao Tokuda, Masahiro Nakajima, Michiaki Kubo, Yusuke Nakamura, Shiro Ikegawa.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by selective motor neuron death in the brain and spinal cord. Many disease genes for ALS have been identified; however, each disease gene is responsible for very small fractions of ALS. Recently, mutations of the gene encoding optineurin (OPTN) are reported in familial and sporadic ALS. OPTN is also responsible for a small number of ALS, 3.8% of familial and 0.29% of sporadic ALS in Japanese. The low prevalence may be an underestimation due to incomplete screening of the mutation. To examine OPTN mutations more extensively, we screened the OPTN deletions using a quantitative PCR system. We examined 710 Japanese ALS subjects who had previously been found to have no OPTN mutations by a screening using a PCR-direct sequence strategy. We identified 3 kinds of deletions in 5 patients; one was homozygous, and the remaining were heterozygous. All deletions occurred due to the Alu-mediated recombination and are expected to result in null alleles. Our results suggest that the OPTN deletion mutation in ALS is not infrequent and the prevalence of the OPTN mutation in Japanese sporadic ALS is considerably high.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402017     DOI: 10.1016/j.neurobiolaging.2011.12.037

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Optineurin: The autophagy connection.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

Review 2.  Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.

Authors:  C Maurel; A Dangoumau; S Marouillat; C Brulard; A Chami; R Hergesheimer; P Corcia; H Blasco; C R Andres; P Vourc'h
Journal:  Mol Neurobiol       Date:  2018-01-10       Impact factor: 5.590

Review 3.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

Review 4.  Autophagy Dysfunction in ALS: from Transport to Protein Degradation.

Authors:  Marta Cozzi; Veronica Ferrari
Journal:  J Mol Neurosci       Date:  2022-06-16       Impact factor: 2.866

5.  OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes.

Authors:  Orly Goldstein; Omri Nayshool; Beatrice Nefussy; Bryan J Traynor; Alan E Renton; Mali Gana-Weisz; Vivian E Drory; Avi Orr-Urtreger
Journal:  Neurology       Date:  2016-01-06       Impact factor: 9.910

Review 6.  Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

Authors:  Shuo-Chien Ling; Magdalini Polymenidou; Don W Cleveland
Journal:  Neuron       Date:  2013-08-07       Impact factor: 17.173

7.  Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo.

Authors:  Mohammad A Esmaeili; Shilpi Yadav; Ravi Kr Gupta; Garrett R Waggoner; Abigail Deloach; Noel Y Calingasan; M Flint Beal; Mahmoud Kiaei
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

8.  Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates.

Authors:  Jelena Korac; Veronique Schaeffer; Igor Kovacevic; Albrecht M Clement; Benno Jungblut; Christian Behl; Janos Terzic; Ivan Dikic
Journal:  J Cell Sci       Date:  2012-11-23       Impact factor: 5.285

9.  Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.

Authors:  Elizabeth T Cirulli; Brittany N Lasseigne; Slavé Petrovski; Peter C Sapp; Patrick A Dion; Claire S Leblond; Julien Couthouis; Yi-Fan Lu; Quanli Wang; Brian J Krueger; Zhong Ren; Jonathan Keebler; Yujun Han; Shawn E Levy; Braden E Boone; Jack R Wimbish; Lindsay L Waite; Angela L Jones; John P Carulli; Aaron G Day-Williams; John F Staropoli; Winnie W Xin; Alessandra Chesi; Alya R Raphael; Diane McKenna-Yasek; Janet Cady; J M B Vianney de Jong; Kevin P Kenna; Bradley N Smith; Simon Topp; Jack Miller; Athina Gkazi; Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink; Vincenzo Silani; Nicola Ticozzi; Christopher E Shaw; Robert H Baloh; Stanley Appel; Ericka Simpson; Clotilde Lagier-Tourenne; Stefan M Pulst; Summer Gibson; John Q Trojanowski; Lauren Elman; Leo McCluskey; Murray Grossman; Neil A Shneider; Wendy K Chung; John M Ravits; Jonathan D Glass; Katherine B Sims; Vivianna M Van Deerlin; Tom Maniatis; Sebastian D Hayes; Alban Ordureau; Sharan Swarup; John Landers; Frank Baas; Andrew S Allen; Richard S Bedlack; J Wade Harper; Aaron D Gitler; Guy A Rouleau; Robert Brown; Matthew B Harms; Gregory M Cooper; Tim Harris; Richard M Myers; David B Goldstein
Journal:  Science       Date:  2015-02-19       Impact factor: 47.728

Review 10.  Protein aggregation in amyotrophic lateral sclerosis.

Authors:  Anna M Blokhuis; Ewout J N Groen; Max Koppers; Leonard H van den Berg; R Jeroen Pasterkamp
Journal:  Acta Neuropathol       Date:  2013-05-15       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.